SlideShare a Scribd company logo
Investor Update
March 2020
Forward-Looking Statements
This presentation may contain forward-looking statements within the meaning of certain securities laws,
including the “safe harbour” provisions of the Securities Act (Ontario) and other provincial securities law in
Canada. These forward-looking statements include, among others, statements with respect to our objectives,
goals and strategies to achieve those objectives and goals, as well as statements with respect to our beliefs,
plans, objectives, expectations, anticipations, estimates and intentions. The words “may”, “will”, “could”,
“should”, “would”, “suspect”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”, “expect”, “intend”, “forecast”,
“objective” and “continue” (or the negative thereof), and words and expressions of similar import, are intended
to identify forward-looking statements. Any such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those projected in these forward-looking statements. For more
information on the risk factors related to these forward-looking statements, please refer to the management’s
discussion and analysis, annual information form and ongoing quarterly filings of Medical Facilities Corporation
available on SEDAR at www.sedar.com.
2
MFC Overview
US$398.1
million
2019 Revenue*
US$96.2
million
2019 Adj. EBITDA*
189
Physician Partners**
US$44.5
million
2019 Income from
Operations*
• HIGHER PATIENT
SATISFACTION ratings
resulting from HIGHER
QUALITY OF CARE
• DIRECT PHYSICIAN
INVOLVEMENT in
facility management,
resulting in SUPERIOR
PROCESSES AND
EFFICIENCIES
* Figures have been modified to reflect continuing operations only, which is defined as
consolidated operations excluding Unity Medical and Surgical Hospital and RRI Mishawaka
Hospital, LP. These entities are treated as discontinued operations in the financial results for
the fourth quarter and year ended December 31, 2019.
** As at December 31, 2019.
Strategic Guiding Principles
MFC delivers value from a strong foundation of high-quality facilities providing
exceptional patient care while exercising prudent financial management that has
resulted in a long track record of solid returns.
Industry leading quality
and service
Focused on maximizing
operating efficiencies
Organic and acquisition
growth strategies
Strong physician-centric
management model
4
Diverse High Quality Portfolio
Specialty Surgical Hospitals
Ambulatory Surgery Centers
• 11 facilities in 10 states
• 62 operating rooms
• 127 overnight beds
• 11 procedure rooms
• 6 urgent care clinics
5
Strong Payor Mix
51%
34%
15%
Private Insurance Medicare/Medicaid Other
38%
34%
28%
Private Insurance Medicare/Medicaid Other
Source: Centers for Medicare & Medicaid Services, National Health Expenditure Projections
2019 MFC Facility Service Revenue 2019 U.S. Healthcare System Revenue
6
Growing Demand for Healthcare
0
15
30
45
60
75
2015 Today 2020 2025 2030
U.S. population aged 65+ (millions)
Drivers:
• Overall population growth
• Aging population
Source: Census.gov 7
The U.S. Healthcare Landscape
Facility type Number Services MFC’s position
Acute Care Hospital Approx. 5,500
General medicine and
surgery, including emergency
and maternity care, open
24/7
Specialty Surgical Hospital <300 physician-owned
Scheduled elective
procedures (e.g. orthopedics,
neurosurgery, pain
management)
Owns 4 in conjunction with
physician partners
Ambulatory Surgery Center Approx. 5,500
Scheduled elective
procedures;
Day surgery only
Owns 7 in conjunction with
physician partners
8
Focused on Growth
9
Expand capacity of
existing facilities
Diversify our revenue
base
Leverage our MFC
Nueterra Partnership
• Recruit new physicians
• Enhance facilities and
equipment through capital
investment
• Add ancillary services
• i.e. urgent care clinics
• Establishes a platform for
growth that facilitates future
acquisitions
Disciplined Approach to Acquisitions
Strict
acquisition
criteria
Accretion, with growth available from a strong
provider base and opportunities for operating
enhancements
High quality and optimum clinical outcomes
Continued strong earnings and
opportunity for growth
1
2
3
10
Operating Results – Q4 2019
1
1 Adjusted EBITDA, cash distributions and payout ratio are non-IFRS financial measures. Please refer to “Non-IFRS Financial Measures” and “Reconciliation of Non-IFRS Financial Measures”
sections in the Management’s Discussion and Analysis.
2 Adjusted for goodwill impairment of $22.0M in Q3’19.
3 Figures have been modified to reflect continuing operations only, which is defined as consolidated operations excluding Unity Medical and Surgical Hospital and RRI Mishawaka Hospital, LP.
These entities are treated as discontinued operations in the financial results for the fourth quarter and year ended December 31, 2019.
(US$ millions, except where noted otherwise) Q4 2019 Q4 2018
Change
%
FY2019 FY2018
Change
%
REVENUE3 114.0 112.0 1.8% 398.1 390.8 1.9%
INCOME FROM OPERATIONS3 25.9 23.8 8.8% 44.5 72.5 (38.7%)
ADJUSTED EBITDA2,3 32.7 30.1 8.5% 96.2 93.4 3.1%
ADJUSTED EBITDA MARGIN2,3 28.7% 26.9% 6.7% 24.2% 23.9% 1.3%
CASH DISTRIBUTIONS
(C$ MILLIONS)
4.4 8.7 (50.0%) 30.6 34.9 (12.3%)
PAYOUT RATIO 37.0% 46.2% (19.9%) 111.1% 71.4% 55.6%
11
Well Resourced for Continued Growth
$32.0
million
Cash& Short-term
Investments
1.08
Net Debt* /
Equity
1.94
Net Debt* /
Adj. EBITDA (LTM)
1.8x
Current Ratio
As at December 31, 2019 12
* inclusive of lease liabilities per IFRS 16
Management Team
David N.T. Watson
Chief Financial Officer
Formerly: Clearway Pain Solutions,
National Surgical Hospitals
Robert O. Horrar
President and Chief Executive Officer
Formerly: Community Health Systems, Humana
James D. Rolfe
Chief Development Officer
Formerly: VMG Health, Community Health Systems
John Schario
Chief Operating Officer
Formerly: Nueterra Healthcare Management,
Mountain States Health Alliance
13
Investment Highlights
• Large, growing & fragmented market for outpatient
services
• Diverse portfolio of highly rated, high quality facilities
• Scalable platform for growth – organically and via
acquisitions
• Experienced, entrepreneurial management team
• Competitive dividend
Capital Markets Profile
As at February 28, 2020
15
Stock Symbol: TSX: DR
Shares Outstanding: 31.1 million
Price: $3.16
Market Capitalization: $98.30 million
Annualized Distribution (per share): $0.28
Current Yield: 8.86%
*All figures in Canadian dollars
To learn more, contact
Trevor Heisler
NATIONAL Capital Markets
416-848-1434
theisler@national.ca

More Related Content

What's hot

SYSCO AND US FOODS MERGER
SYSCO AND US FOODS MERGERSYSCO AND US FOODS MERGER
SYSCO AND US FOODS MERGER
Mark Moreno
 
Dublin day deck 6.1.17 final (1)
Dublin day deck 6.1.17 final (1)Dublin day deck 6.1.17 final (1)
Dublin day deck 6.1.17 final (1)
Cardinal_Health
 
DSS Presentation Deck 2021
DSS Presentation Deck 2021DSS Presentation Deck 2021
DSS Presentation Deck 2021
RedChip Companies, Inc.
 
DSS Presentation Deck Dec 2021
DSS Presentation Deck  Dec 2021DSS Presentation Deck  Dec 2021
DSS Presentation Deck Dec 2021
RedChip Companies, Inc.
 
Q3 2017 earnings charts final
Q3 2017 earnings charts   finalQ3 2017 earnings charts   final
Q3 2017 earnings charts final
pfizer_ir
 
Dsp investor deck september 2017 final
Dsp investor deck september 2017 finalDsp investor deck september 2017 final
Dsp investor deck september 2017 final
DiplomatIR
 
Medicine Man Tech Presentation
Medicine Man Tech PresentationMedicine Man Tech Presentation
Medicine Man Tech Presentation
RedChip Companies, Inc.
 
BTTR Investor Presentation - August 2020
BTTR Investor Presentation - August 2020BTTR Investor Presentation - August 2020
BTTR Investor Presentation - August 2020
RedChip Companies, Inc.
 
3Q FY2017 Earnings Presentation
3Q FY2017 Earnings Presentation3Q FY2017 Earnings Presentation
3Q FY2017 Earnings Presentation
Cardinal_Health
 
BTTR Investor Presentation - April 2020
BTTR Investor Presentation - April 2020BTTR Investor Presentation - April 2020
BTTR Investor Presentation - April 2020
RedChip Companies, Inc.
 
Flower One Investor Presentation March
Flower One Investor Presentation MarchFlower One Investor Presentation March
Flower One Investor Presentation March
Flower One Holdings Inc.
 
CDIF investor presentation
CDIF investor presentationCDIF investor presentation
CDIF investor presentation
RedChip Companies, Inc.
 
Cogint management investor presentation
Cogint management investor presentationCogint management investor presentation
Cogint management investor presentation
RedChip Companies, Inc.
 
Aveda energy investor presentation september 2013
Aveda energy investor presentation september  2013Aveda energy investor presentation september  2013
Aveda energy investor presentation september 2013
AvedaEnergy
 
Aurora investor presentation acquisition of canni-med therapeutics
 Aurora investor presentation   acquisition of canni-med therapeutics Aurora investor presentation   acquisition of canni-med therapeutics
Aurora investor presentation acquisition of canni-med therapeutics
Marc Lakmaaker
 
Pfizer Q2 2017 Earnings Charts
Pfizer Q2 2017 Earnings ChartsPfizer Q2 2017 Earnings Charts
Pfizer Q2 2017 Earnings Charts
pfizer_ir
 
Q1 2021 Earnings Presentation
Q1 2021 Earnings PresentationQ1 2021 Earnings Presentation
Q1 2021 Earnings Presentation
QTSDataCenters
 
First quarter 2014 investor presentation
First quarter 2014 investor presentationFirst quarter 2014 investor presentation
First quarter 2014 investor presentation
Thor_Industries
 
Brink's Investor Meetings August 2017
Brink's Investor Meetings August 2017 Brink's Investor Meetings August 2017
Brink's Investor Meetings August 2017
investorsbrinks
 
Pfizer Financial Analysis
Pfizer Financial AnalysisPfizer Financial Analysis
Pfizer Financial Analysis
Riley Bannon
 

What's hot (20)

SYSCO AND US FOODS MERGER
SYSCO AND US FOODS MERGERSYSCO AND US FOODS MERGER
SYSCO AND US FOODS MERGER
 
Dublin day deck 6.1.17 final (1)
Dublin day deck 6.1.17 final (1)Dublin day deck 6.1.17 final (1)
Dublin day deck 6.1.17 final (1)
 
DSS Presentation Deck 2021
DSS Presentation Deck 2021DSS Presentation Deck 2021
DSS Presentation Deck 2021
 
DSS Presentation Deck Dec 2021
DSS Presentation Deck  Dec 2021DSS Presentation Deck  Dec 2021
DSS Presentation Deck Dec 2021
 
Q3 2017 earnings charts final
Q3 2017 earnings charts   finalQ3 2017 earnings charts   final
Q3 2017 earnings charts final
 
Dsp investor deck september 2017 final
Dsp investor deck september 2017 finalDsp investor deck september 2017 final
Dsp investor deck september 2017 final
 
Medicine Man Tech Presentation
Medicine Man Tech PresentationMedicine Man Tech Presentation
Medicine Man Tech Presentation
 
BTTR Investor Presentation - August 2020
BTTR Investor Presentation - August 2020BTTR Investor Presentation - August 2020
BTTR Investor Presentation - August 2020
 
3Q FY2017 Earnings Presentation
3Q FY2017 Earnings Presentation3Q FY2017 Earnings Presentation
3Q FY2017 Earnings Presentation
 
BTTR Investor Presentation - April 2020
BTTR Investor Presentation - April 2020BTTR Investor Presentation - April 2020
BTTR Investor Presentation - April 2020
 
Flower One Investor Presentation March
Flower One Investor Presentation MarchFlower One Investor Presentation March
Flower One Investor Presentation March
 
CDIF investor presentation
CDIF investor presentationCDIF investor presentation
CDIF investor presentation
 
Cogint management investor presentation
Cogint management investor presentationCogint management investor presentation
Cogint management investor presentation
 
Aveda energy investor presentation september 2013
Aveda energy investor presentation september  2013Aveda energy investor presentation september  2013
Aveda energy investor presentation september 2013
 
Aurora investor presentation acquisition of canni-med therapeutics
 Aurora investor presentation   acquisition of canni-med therapeutics Aurora investor presentation   acquisition of canni-med therapeutics
Aurora investor presentation acquisition of canni-med therapeutics
 
Pfizer Q2 2017 Earnings Charts
Pfizer Q2 2017 Earnings ChartsPfizer Q2 2017 Earnings Charts
Pfizer Q2 2017 Earnings Charts
 
Q1 2021 Earnings Presentation
Q1 2021 Earnings PresentationQ1 2021 Earnings Presentation
Q1 2021 Earnings Presentation
 
First quarter 2014 investor presentation
First quarter 2014 investor presentationFirst quarter 2014 investor presentation
First quarter 2014 investor presentation
 
Brink's Investor Meetings August 2017
Brink's Investor Meetings August 2017 Brink's Investor Meetings August 2017
Brink's Investor Meetings August 2017
 
Pfizer Financial Analysis
Pfizer Financial AnalysisPfizer Financial Analysis
Pfizer Financial Analysis
 

Similar to Medical Facilities Corporation - Investor Update - March 2020

Medical Facilities Corporation - Investor Presentation - October 2020
Medical Facilities Corporation - Investor Presentation - October 2020Medical Facilities Corporation - Investor Presentation - October 2020
Medical Facilities Corporation - Investor Presentation - October 2020
SharePitch
 
Medical Facilities Corporation - 2020 Annual Report
Medical Facilities Corporation - 2020 Annual ReportMedical Facilities Corporation - 2020 Annual Report
Medical Facilities Corporation - 2020 Annual Report
SharePitch
 
Mercer Capital's Value Focus: Medical Technology | Q2 2022
Mercer Capital's Value Focus: Medical Technology | Q2 2022Mercer Capital's Value Focus: Medical Technology | Q2 2022
Mercer Capital's Value Focus: Medical Technology | Q2 2022
Mercer Capital
 
Financial Planning In Healthcare PowerPoint Presentation Slides
Financial Planning In Healthcare PowerPoint Presentation Slides Financial Planning In Healthcare PowerPoint Presentation Slides
Financial Planning In Healthcare PowerPoint Presentation Slides
SlideTeam
 
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021
Mercer Capital
 
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...
Mercer Capital
 
Monetary Administration In Healthcare PowerPoint Presentation Slides
Monetary Administration In Healthcare PowerPoint Presentation Slides Monetary Administration In Healthcare PowerPoint Presentation Slides
Monetary Administration In Healthcare PowerPoint Presentation Slides
SlideTeam
 
Bionic Presentation-August-2020-(FINAL)-8.17.20.pdf
Bionic Presentation-August-2020-(FINAL)-8.17.20.pdfBionic Presentation-August-2020-(FINAL)-8.17.20.pdf
Bionic Presentation-August-2020-(FINAL)-8.17.20.pdf
ssuser3fcdc51
 
NeoGenomics Company Overview Presentation 2013
NeoGenomics Company Overview Presentation 2013NeoGenomics Company Overview Presentation 2013
NeoGenomics Company Overview Presentation 2013
NeoGenomics Laboratory | Cancer Diagnostics
 
Canada Healthcare Claims Management Market Analysis Sample Report
Canada Healthcare Claims Management Market Analysis Sample ReportCanada Healthcare Claims Management Market Analysis Sample Report
Canada Healthcare Claims Management Market Analysis Sample Report
Insights10
 
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014
Mercer Capital
 
Agility health investor presentation - investor tab 07.18.16
Agility health   investor presentation - investor tab 07.18.16Agility health   investor presentation - investor tab 07.18.16
Agility health investor presentation - investor tab 07.18.16
AgilityHealth
 
Quality Systems Presentation 04/01/10
Quality Systems Presentation 04/01/10Quality Systems Presentation 04/01/10
Quality Systems Presentation 04/01/10
Quality Systems, Inc.
 
NeoGenomics Company Overview Presentation 12/04/2013
NeoGenomics Company Overview Presentation 12/04/2013NeoGenomics Company Overview Presentation 12/04/2013
NeoGenomics Company Overview Presentation 12/04/2013
NeoGenomics Laboratory | Cancer Diagnostics
 
2013 12 04 neo company overview presentation
2013 12 04   neo company overview presentation2013 12 04   neo company overview presentation
2013 12 04 neo company overview presentation
NeoGenomics Laboratory | Cancer Diagnostics
 
Tenet-2022-JPM-Presentation.pdf
Tenet-2022-JPM-Presentation.pdfTenet-2022-JPM-Presentation.pdf
Tenet-2022-JPM-Presentation.pdf
MOHAMMED YASER HUSSAIN
 
Commercial Management In Healthcare PowerPoint Presentation Slides
Commercial Management In Healthcare PowerPoint Presentation Slides Commercial Management In Healthcare PowerPoint Presentation Slides
Commercial Management In Healthcare PowerPoint Presentation Slides
SlideTeam
 
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...
Uday M
 
NeoGenomics Company Overview Presentation 2013_10_23
NeoGenomics Company Overview Presentation 2013_10_23 NeoGenomics Company Overview Presentation 2013_10_23
NeoGenomics Company Overview Presentation 2013_10_23
NeoGenomics Laboratory | Cancer Diagnostics
 
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |
Mercer Capital
 

Similar to Medical Facilities Corporation - Investor Update - March 2020 (20)

Medical Facilities Corporation - Investor Presentation - October 2020
Medical Facilities Corporation - Investor Presentation - October 2020Medical Facilities Corporation - Investor Presentation - October 2020
Medical Facilities Corporation - Investor Presentation - October 2020
 
Medical Facilities Corporation - 2020 Annual Report
Medical Facilities Corporation - 2020 Annual ReportMedical Facilities Corporation - 2020 Annual Report
Medical Facilities Corporation - 2020 Annual Report
 
Mercer Capital's Value Focus: Medical Technology | Q2 2022
Mercer Capital's Value Focus: Medical Technology | Q2 2022Mercer Capital's Value Focus: Medical Technology | Q2 2022
Mercer Capital's Value Focus: Medical Technology | Q2 2022
 
Financial Planning In Healthcare PowerPoint Presentation Slides
Financial Planning In Healthcare PowerPoint Presentation Slides Financial Planning In Healthcare PowerPoint Presentation Slides
Financial Planning In Healthcare PowerPoint Presentation Slides
 
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021
 
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...
 
Monetary Administration In Healthcare PowerPoint Presentation Slides
Monetary Administration In Healthcare PowerPoint Presentation Slides Monetary Administration In Healthcare PowerPoint Presentation Slides
Monetary Administration In Healthcare PowerPoint Presentation Slides
 
Bionic Presentation-August-2020-(FINAL)-8.17.20.pdf
Bionic Presentation-August-2020-(FINAL)-8.17.20.pdfBionic Presentation-August-2020-(FINAL)-8.17.20.pdf
Bionic Presentation-August-2020-(FINAL)-8.17.20.pdf
 
NeoGenomics Company Overview Presentation 2013
NeoGenomics Company Overview Presentation 2013NeoGenomics Company Overview Presentation 2013
NeoGenomics Company Overview Presentation 2013
 
Canada Healthcare Claims Management Market Analysis Sample Report
Canada Healthcare Claims Management Market Analysis Sample ReportCanada Healthcare Claims Management Market Analysis Sample Report
Canada Healthcare Claims Management Market Analysis Sample Report
 
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014
 
Agility health investor presentation - investor tab 07.18.16
Agility health   investor presentation - investor tab 07.18.16Agility health   investor presentation - investor tab 07.18.16
Agility health investor presentation - investor tab 07.18.16
 
Quality Systems Presentation 04/01/10
Quality Systems Presentation 04/01/10Quality Systems Presentation 04/01/10
Quality Systems Presentation 04/01/10
 
NeoGenomics Company Overview Presentation 12/04/2013
NeoGenomics Company Overview Presentation 12/04/2013NeoGenomics Company Overview Presentation 12/04/2013
NeoGenomics Company Overview Presentation 12/04/2013
 
2013 12 04 neo company overview presentation
2013 12 04   neo company overview presentation2013 12 04   neo company overview presentation
2013 12 04 neo company overview presentation
 
Tenet-2022-JPM-Presentation.pdf
Tenet-2022-JPM-Presentation.pdfTenet-2022-JPM-Presentation.pdf
Tenet-2022-JPM-Presentation.pdf
 
Commercial Management In Healthcare PowerPoint Presentation Slides
Commercial Management In Healthcare PowerPoint Presentation Slides Commercial Management In Healthcare PowerPoint Presentation Slides
Commercial Management In Healthcare PowerPoint Presentation Slides
 
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...
 
NeoGenomics Company Overview Presentation 2013_10_23
NeoGenomics Company Overview Presentation 2013_10_23 NeoGenomics Company Overview Presentation 2013_10_23
NeoGenomics Company Overview Presentation 2013_10_23
 
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |
 

More from SharePitch

D-BOX - Q3 2023 Investor Update.pdf
D-BOX - Q3 2023 Investor Update.pdfD-BOX - Q3 2023 Investor Update.pdf
D-BOX - Q3 2023 Investor Update.pdf
SharePitch
 
Precision Biomonitoring - TSX Life Science Day - February 2021
Precision Biomonitoring - TSX Life Science Day - February 2021Precision Biomonitoring - TSX Life Science Day - February 2021
Precision Biomonitoring - TSX Life Science Day - February 2021
SharePitch
 
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020Ceres Global Ag - Annual Meeting Presentation - November 12, 2020
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020
SharePitch
 
Medical Facilities Corporation - 2019 Annual Report
Medical Facilities Corporation - 2019 Annual ReportMedical Facilities Corporation - 2019 Annual Report
Medical Facilities Corporation - 2019 Annual Report
SharePitch
 
Flower One Holdings - Investor Presentation - April 2020
Flower One Holdings - Investor Presentation - April 2020Flower One Holdings - Investor Presentation - April 2020
Flower One Holdings - Investor Presentation - April 2020
SharePitch
 
Centric Health Corporation - Investor Presentation - April 2020
Centric Health Corporation - Investor Presentation - April 2020Centric Health Corporation - Investor Presentation - April 2020
Centric Health Corporation - Investor Presentation - April 2020
SharePitch
 

More from SharePitch (6)

D-BOX - Q3 2023 Investor Update.pdf
D-BOX - Q3 2023 Investor Update.pdfD-BOX - Q3 2023 Investor Update.pdf
D-BOX - Q3 2023 Investor Update.pdf
 
Precision Biomonitoring - TSX Life Science Day - February 2021
Precision Biomonitoring - TSX Life Science Day - February 2021Precision Biomonitoring - TSX Life Science Day - February 2021
Precision Biomonitoring - TSX Life Science Day - February 2021
 
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020Ceres Global Ag - Annual Meeting Presentation - November 12, 2020
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020
 
Medical Facilities Corporation - 2019 Annual Report
Medical Facilities Corporation - 2019 Annual ReportMedical Facilities Corporation - 2019 Annual Report
Medical Facilities Corporation - 2019 Annual Report
 
Flower One Holdings - Investor Presentation - April 2020
Flower One Holdings - Investor Presentation - April 2020Flower One Holdings - Investor Presentation - April 2020
Flower One Holdings - Investor Presentation - April 2020
 
Centric Health Corporation - Investor Presentation - April 2020
Centric Health Corporation - Investor Presentation - April 2020Centric Health Corporation - Investor Presentation - April 2020
Centric Health Corporation - Investor Presentation - April 2020
 

Recently uploaded

快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
f3wjr2q2
 
Cleades robinson:The Diplomat is Blue
Cleades robinson:The Diplomat is BlueCleades robinson:The Diplomat is Blue
Cleades robinson:The Diplomat is Blue
Cleades Robinson
 
Mandalay Resouces June 2024 Investor Relations PPT
Mandalay Resouces June 2024 Investor Relations PPTMandalay Resouces June 2024 Investor Relations PPT
Mandalay Resouces June 2024 Investor Relations PPT
MandalayResources
 
Methanex Investor Presentation - April 2024
Methanex Investor Presentation - April 2024Methanex Investor Presentation - April 2024
Methanex Investor Presentation - April 2024
Methanex Corporation
 
mba project CRED.docx report for students final year
mba project CRED.docx report for students final yearmba project CRED.docx report for students final year
mba project CRED.docx report for students final year
JyothisaiBhavya4
 
Cove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdf
Cove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdfCove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdf
Cove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdf
kboyd6
 
Corporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdfCorporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdf
Probe Gold
 
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd
 
Collective Mining | Corporate Presentation - June 2024
Collective Mining  | Corporate Presentation - June 2024Collective Mining  | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
CollectiveMining1
 
UnityNet World Environment Day Abraham Project 2024 Press Release
UnityNet World Environment Day Abraham Project 2024 Press ReleaseUnityNet World Environment Day Abraham Project 2024 Press Release
UnityNet World Environment Day Abraham Project 2024 Press Release
LHelferty
 
Cyberagent_For New Investors_EN_240424.pdf
Cyberagent_For New Investors_EN_240424.pdfCyberagent_For New Investors_EN_240424.pdf
Cyberagent_For New Investors_EN_240424.pdf
CyberAgent, Inc.
 
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdfZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
SOFTTECHHUB
 
AGM Presentation Probe June 11 Final.pdf
AGM Presentation Probe June 11 Final.pdfAGM Presentation Probe June 11 Final.pdf
AGM Presentation Probe June 11 Final.pdf
Probe Gold
 
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
CollectiveMining1
 
ppt-namibia-worldeconomy-standardbank.ppt
ppt-namibia-worldeconomy-standardbank.pptppt-namibia-worldeconomy-standardbank.ppt
ppt-namibia-worldeconomy-standardbank.ppt
TestOrg1
 

Recently uploaded (15)

快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
 
Cleades robinson:The Diplomat is Blue
Cleades robinson:The Diplomat is BlueCleades robinson:The Diplomat is Blue
Cleades robinson:The Diplomat is Blue
 
Mandalay Resouces June 2024 Investor Relations PPT
Mandalay Resouces June 2024 Investor Relations PPTMandalay Resouces June 2024 Investor Relations PPT
Mandalay Resouces June 2024 Investor Relations PPT
 
Methanex Investor Presentation - April 2024
Methanex Investor Presentation - April 2024Methanex Investor Presentation - April 2024
Methanex Investor Presentation - April 2024
 
mba project CRED.docx report for students final year
mba project CRED.docx report for students final yearmba project CRED.docx report for students final year
mba project CRED.docx report for students final year
 
Cove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdf
Cove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdfCove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdf
Cove Multifamily Income Fund 28 LLC IOI 3.3.2021 (1).pdf
 
Corporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdfCorporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdf
 
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
 
Collective Mining | Corporate Presentation - June 2024
Collective Mining  | Corporate Presentation - June 2024Collective Mining  | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
 
UnityNet World Environment Day Abraham Project 2024 Press Release
UnityNet World Environment Day Abraham Project 2024 Press ReleaseUnityNet World Environment Day Abraham Project 2024 Press Release
UnityNet World Environment Day Abraham Project 2024 Press Release
 
Cyberagent_For New Investors_EN_240424.pdf
Cyberagent_For New Investors_EN_240424.pdfCyberagent_For New Investors_EN_240424.pdf
Cyberagent_For New Investors_EN_240424.pdf
 
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdfZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
 
AGM Presentation Probe June 11 Final.pdf
AGM Presentation Probe June 11 Final.pdfAGM Presentation Probe June 11 Final.pdf
AGM Presentation Probe June 11 Final.pdf
 
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
 
ppt-namibia-worldeconomy-standardbank.ppt
ppt-namibia-worldeconomy-standardbank.pptppt-namibia-worldeconomy-standardbank.ppt
ppt-namibia-worldeconomy-standardbank.ppt
 

Medical Facilities Corporation - Investor Update - March 2020

  • 2. Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of certain securities laws, including the “safe harbour” provisions of the Securities Act (Ontario) and other provincial securities law in Canada. These forward-looking statements include, among others, statements with respect to our objectives, goals and strategies to achieve those objectives and goals, as well as statements with respect to our beliefs, plans, objectives, expectations, anticipations, estimates and intentions. The words “may”, “will”, “could”, “should”, “would”, “suspect”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”, “expect”, “intend”, “forecast”, “objective” and “continue” (or the negative thereof), and words and expressions of similar import, are intended to identify forward-looking statements. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these forward-looking statements. For more information on the risk factors related to these forward-looking statements, please refer to the management’s discussion and analysis, annual information form and ongoing quarterly filings of Medical Facilities Corporation available on SEDAR at www.sedar.com. 2
  • 3. MFC Overview US$398.1 million 2019 Revenue* US$96.2 million 2019 Adj. EBITDA* 189 Physician Partners** US$44.5 million 2019 Income from Operations* • HIGHER PATIENT SATISFACTION ratings resulting from HIGHER QUALITY OF CARE • DIRECT PHYSICIAN INVOLVEMENT in facility management, resulting in SUPERIOR PROCESSES AND EFFICIENCIES * Figures have been modified to reflect continuing operations only, which is defined as consolidated operations excluding Unity Medical and Surgical Hospital and RRI Mishawaka Hospital, LP. These entities are treated as discontinued operations in the financial results for the fourth quarter and year ended December 31, 2019. ** As at December 31, 2019.
  • 4. Strategic Guiding Principles MFC delivers value from a strong foundation of high-quality facilities providing exceptional patient care while exercising prudent financial management that has resulted in a long track record of solid returns. Industry leading quality and service Focused on maximizing operating efficiencies Organic and acquisition growth strategies Strong physician-centric management model 4
  • 5. Diverse High Quality Portfolio Specialty Surgical Hospitals Ambulatory Surgery Centers • 11 facilities in 10 states • 62 operating rooms • 127 overnight beds • 11 procedure rooms • 6 urgent care clinics 5
  • 6. Strong Payor Mix 51% 34% 15% Private Insurance Medicare/Medicaid Other 38% 34% 28% Private Insurance Medicare/Medicaid Other Source: Centers for Medicare & Medicaid Services, National Health Expenditure Projections 2019 MFC Facility Service Revenue 2019 U.S. Healthcare System Revenue 6
  • 7. Growing Demand for Healthcare 0 15 30 45 60 75 2015 Today 2020 2025 2030 U.S. population aged 65+ (millions) Drivers: • Overall population growth • Aging population Source: Census.gov 7
  • 8. The U.S. Healthcare Landscape Facility type Number Services MFC’s position Acute Care Hospital Approx. 5,500 General medicine and surgery, including emergency and maternity care, open 24/7 Specialty Surgical Hospital <300 physician-owned Scheduled elective procedures (e.g. orthopedics, neurosurgery, pain management) Owns 4 in conjunction with physician partners Ambulatory Surgery Center Approx. 5,500 Scheduled elective procedures; Day surgery only Owns 7 in conjunction with physician partners 8
  • 9. Focused on Growth 9 Expand capacity of existing facilities Diversify our revenue base Leverage our MFC Nueterra Partnership • Recruit new physicians • Enhance facilities and equipment through capital investment • Add ancillary services • i.e. urgent care clinics • Establishes a platform for growth that facilitates future acquisitions
  • 10. Disciplined Approach to Acquisitions Strict acquisition criteria Accretion, with growth available from a strong provider base and opportunities for operating enhancements High quality and optimum clinical outcomes Continued strong earnings and opportunity for growth 1 2 3 10
  • 11. Operating Results – Q4 2019 1 1 Adjusted EBITDA, cash distributions and payout ratio are non-IFRS financial measures. Please refer to “Non-IFRS Financial Measures” and “Reconciliation of Non-IFRS Financial Measures” sections in the Management’s Discussion and Analysis. 2 Adjusted for goodwill impairment of $22.0M in Q3’19. 3 Figures have been modified to reflect continuing operations only, which is defined as consolidated operations excluding Unity Medical and Surgical Hospital and RRI Mishawaka Hospital, LP. These entities are treated as discontinued operations in the financial results for the fourth quarter and year ended December 31, 2019. (US$ millions, except where noted otherwise) Q4 2019 Q4 2018 Change % FY2019 FY2018 Change % REVENUE3 114.0 112.0 1.8% 398.1 390.8 1.9% INCOME FROM OPERATIONS3 25.9 23.8 8.8% 44.5 72.5 (38.7%) ADJUSTED EBITDA2,3 32.7 30.1 8.5% 96.2 93.4 3.1% ADJUSTED EBITDA MARGIN2,3 28.7% 26.9% 6.7% 24.2% 23.9% 1.3% CASH DISTRIBUTIONS (C$ MILLIONS) 4.4 8.7 (50.0%) 30.6 34.9 (12.3%) PAYOUT RATIO 37.0% 46.2% (19.9%) 111.1% 71.4% 55.6% 11
  • 12. Well Resourced for Continued Growth $32.0 million Cash& Short-term Investments 1.08 Net Debt* / Equity 1.94 Net Debt* / Adj. EBITDA (LTM) 1.8x Current Ratio As at December 31, 2019 12 * inclusive of lease liabilities per IFRS 16
  • 13. Management Team David N.T. Watson Chief Financial Officer Formerly: Clearway Pain Solutions, National Surgical Hospitals Robert O. Horrar President and Chief Executive Officer Formerly: Community Health Systems, Humana James D. Rolfe Chief Development Officer Formerly: VMG Health, Community Health Systems John Schario Chief Operating Officer Formerly: Nueterra Healthcare Management, Mountain States Health Alliance 13
  • 14. Investment Highlights • Large, growing & fragmented market for outpatient services • Diverse portfolio of highly rated, high quality facilities • Scalable platform for growth – organically and via acquisitions • Experienced, entrepreneurial management team • Competitive dividend
  • 15. Capital Markets Profile As at February 28, 2020 15 Stock Symbol: TSX: DR Shares Outstanding: 31.1 million Price: $3.16 Market Capitalization: $98.30 million Annualized Distribution (per share): $0.28 Current Yield: 8.86% *All figures in Canadian dollars
  • 16. To learn more, contact Trevor Heisler NATIONAL Capital Markets 416-848-1434 theisler@national.ca